Looks like it’s gap fill time. The futures are strong this morning and have put the Nasdaq and S&P well within their February gaps. This should make for an interesting day.
On Today’s Calendar:
- nothing
More Calendars: U.S. Earnings | Conf. Calls | Surprises | IPO | Economic
Potential swing trades:
See one of the recent ‘Chart Reading‘ posts for some potential swing candidates.
Potential day trades:
(From Briefing.com)
Gapping Down
DAKT -18% (guides below consensus), AHM -17% (guides lower, also Lehman downgrade; mortgage stocks down in sympathy: NDE -3.7%, CFC -3.5%), VG -14% (judge tells co it cannot seek new customers – WSJ), ARIA -9.5% (delays cancer drug trial), ENCY -7.2% (prices stock offering), ACLS -5.1% (Lehman downgrade), HLF -4.5% (terminates talks with Whitney), FIRE -3.5% (pre-reports Q1 results), NRMX -3.1% (profit taking after 10% move on Thursday), MTRX -2.3% (profit taking after 15% move on Thursday), BRLC -1.7%
Gapping Up
DOW +8.4% (The Sunday Express reports that a consortium of investors is preparing a $50 bln bid), USAT +20% (announces deal with large bottler), NCTY +14% (ERTS to buy 19% stake in co – Reuters), ANR +11.5% (Sun Capital discloses 5% stake in 13G filing), ALLT +11% (mentioned positively in Barron’s), DNDN +11% (extends 20% move from last Thursday, other biotechs also moving: NUVO +19%, CVTX +9%, SIGA +4.8%, CEGE +4.6%), SCHN +10% (reports FebQ), SCUR +8.3% (mentioned positively in Barron’s), NETL +5.4% (guides higher, announces mgmt changes), STEM +4.8% (trading up ahead of stem cell vote this week; also ASTM +6%), BNI +3.7% (Berkshire acquires 10.9% stake — NY Times), MEDI +2.5% (gudies above consensus), SUNW +1.2%, Under $3: MEMY +31% (completes Phase 2 study enrollment).
Disclaimer & How I use this list
